Выпуск
Daily Briefing for November 7, 2026
Physician in the Loop · 7 ноября 2026 г. · 5 мин
U.S. measles cases pass 5,000, the most since 1991 The voices on this episode are generated, and so is the script, from the day's post at Physician in the Loop. Every fact in the post links to its source. Read the post and its sources Get the free email briefing The United States has recorded 5,182 confirmed measles cases in 2026, the most since 1991, federal data released Friday showed, days before a regional review that could end the country's measles elimination status. The count is more than double the 2,289 cases of 2025, and children and teenagers make up about 59% of them, according to Centers for Disease Control and Prevention figures reported by Bloomberg and Al Jazeera. The Pan American Health Organization said in March that it would review U.S. elimination status at its November meeting; a country loses the status after 12 months of uninterrupted spread of one viral lineage. The Food and Drug Administration also opened an investigation of tumors in patients treated with the spinal muscular atrophy gene therapy Zolgensma, and HCA Healthcare said about 10,000 of its physicians will be documenting with ambient AI by year's end. In this episode U.S. measles cases reach 5,182, the most since 1991, as elimination status goes up for review next week FDA investigates tumors after Zolgensma gene therapy, with viral DNA found inserted near a cancer gene in two patients HCA Healthcare puts ambient AI in the hands of 10,000 physicians by year's end and an AI nurse handoff tool in 100 hospitals An AI flag on positive ANA tests cut time to autoimmune diagnosis from 138 to 43 days in a Vanderbilt randomized trial Medicare cuts 340B drug payments to sales price minus 28% and pays office rates for hospital imaging off campus from 2027 Ochsner plans primary care panels of 3,000 to 5,000 patients built around AI agents, pharmacists and ambient listening Starting overactive bladder patients on beta-3 agonists instead of anticholinergics did not lower dementia risk in an 830,393-patient cohort